Literature DB >> 27023631

Regulation of lipid metabolism by angiopoietin-like proteins.

Wieneke Dijk1, Sander Kersten.   

Abstract

PURPOSE OF REVIEW: The angiopoietin-like proteins (ANGPTLs) 3, 4 and 8 have emerged as key regulators of plasma lipid metabolism by serving as potent inhibitors of the enzyme lipoprotein lipase (LPL). In this review, we provide an integrated picture of the role of ANGPTL3, ANGPTL4 and ANGPTL8 in lipid metabolism by focusing on their impact on LPL activity and plasma triglyceride clearance during physiological conditions such as fasting, refeeding, exercise and cold exposure. RECENT
FINDINGS: Upon refeeding, circulating ANGPTL3 and ANGPTL8 promote the replenishment of white adipose tissue depots by specifically inhibiting LPL activity in oxidative tissues. During exercise and cold exposure, ANGPTL4 represses local LPL activity to assure that plasma triglycerides are specifically shuttled to exercising muscle and brown adipose tissue, respectively. Overall, ANGPTL4 is the central component of a fatty acid-driven feedback mechanism that regulates plasma triglyceride hydrolysis and subsequent tissue fatty acid uptake in response to changes in lipid availability and cellular fuel demand.
SUMMARY: ANGPTL3, ANGPTL4 and ANGPTL8 together ensure that triglycerides from triglyceride-rich lipoproteins are adequately distributed during different physiological conditions. The impact of the ANGPTLs on plasma lipid levels has led to scrutiny of ANGPTLs as therapeutic targets for dyslipidemia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27023631     DOI: 10.1097/MOL.0000000000000290

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  62 in total

Review 1.  ANGPTL4 in Metabolic and Cardiovascular Disease.

Authors:  Binod Aryal; Nathan L Price; Yajaira Suarez; Carlos Fernández-Hernando
Journal:  Trends Mol Med       Date:  2019-06-21       Impact factor: 11.951

Review 2.  Distinct but complementary contributions of PPAR isotypes to energy homeostasis.

Authors:  Vanessa Dubois; Jérôme Eeckhoute; Philippe Lefebvre; Bart Staels
Journal:  J Clin Invest       Date:  2017-04-03       Impact factor: 14.808

3.  Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.

Authors:  Ranganath Muniyappa; Brent S Abel; Asha Asthana; Mary F Walter; Elaine K Cochran; Alan T Remaley; Monica C Skarulis; Phillip Gorden; Rebecca J Brown
Journal:  J Clin Lipidol       Date:  2017-02-24       Impact factor: 4.766

4.  Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.

Authors:  Charlotte Koopal; Remy Bemelmans; A David Marais; Frank Lj Visseren
Journal:  BMJ Case Rep       Date:  2019-04-03

5.  Multidimensional regulation of lipoprotein lipase: impact on biochemical and cardiovascular phenotypes.

Authors:  Robert A Hegele
Journal:  J Lipid Res       Date:  2016-07-13       Impact factor: 5.922

6.  Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry.

Authors:  Mart Reimund; Oleg Kovrov; Gunilla Olivecrona; Aivar Lookene
Journal:  J Lipid Res       Date:  2016-11-14       Impact factor: 5.922

7.  Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice.

Authors:  Antwi-Boasiako Oteng; Philip M M Ruppert; Lily Boutens; Wieneke Dijk; Xanthe A M H van Dierendonck; Gunilla Olivecrona; Rinke Stienstra; Sander Kersten
Journal:  J Lipid Res       Date:  2019-08-13       Impact factor: 5.922

8.  Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3/furin in adipocytes.

Authors:  Wieneke Dijk; Philip M M Ruppert; Lynette J Oost; Sander Kersten
Journal:  J Biol Chem       Date:  2018-07-18       Impact factor: 5.157

9.  Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.

Authors:  Akrit Sodhi; Tao Ma; Deepak Menon; Monika Deshpande; Kathleen Jee; Aumreetam Dinabandhu; Jordan Vancel; Daoyuan Lu; Silvia Montaner
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

10.  ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.

Authors:  Barnabas Gellen; Nathalie Thorin-Trescases; Philippe Sosner; Elise Gand; Pierre-Jean Saulnier; Stéphanie Ragot; Mathilde Fraty; Stéphanie Laugier; Grégory Ducrocq; David Montaigne; Pierre Llaty; Vincent Rigalleau; Philippe Zaoui; Jean-Michel Halimi; Ronan Roussel; Eric Thorin; Samy Hadjadj
Journal:  Diabetologia       Date:  2016-08-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.